世界の注射用エノキサパリンナトリウム市場予測2023-2029:40mg、100mg、その他

【英語タイトル】Enoxaparin Sodium For Injection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5540)・商品コード:MMG23JU5540
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:73
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の注射用エノキサパリンナトリウム市場規模と予測を収録しています。・世界の注射用エノキサパリンナトリウム市場:売上、2018年-2023年、2024年-2029年
・世界の注射用エノキサパリンナトリウム市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用エノキサパリンナトリウム市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「40mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

注射用エノキサパリンナトリウムのグローバル主要企業は、Sanofi、 Teva Pharmaceutical、 Techdow (Hepalink)、 Fresenius Kabi、 Amphastar Pharmaceuticals、 Hangzhou Jiuyuan Gene Engineering、 Suzhou Erye Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Chengdu Baiyu Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Beijing SL Pharmaceutical、 Troikaa Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、注射用エノキサパリンナトリウムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の注射用エノキサパリンナトリウム市場:タイプ別、2018年-2023年、2024年-2029年
世界の注射用エノキサパリンナトリウム市場:タイプ別市場シェア、2022年
・40mg、100mg、その他

世界の注射用エノキサパリンナトリウム市場:用途別、2018年-2023年、2024年-2029年
世界の注射用エノキサパリンナトリウム市場:用途別市場シェア、2022年
・静脈血栓症の予防、深部静脈塞栓症の治療、その他

世界の注射用エノキサパリンナトリウム市場:地域・国別、2018年-2023年、2024年-2029年
世界の注射用エノキサパリンナトリウム市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における注射用エノキサパリンナトリウムのグローバル売上、2018年-2023年
・主要企業における注射用エノキサパリンナトリウムのグローバル売上シェア、2022年
・主要企業における注射用エノキサパリンナトリウムのグローバル販売量、2018年-2023年
・主要企業における注射用エノキサパリンナトリウムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi、 Teva Pharmaceutical、 Techdow (Hepalink)、 Fresenius Kabi、 Amphastar Pharmaceuticals、 Hangzhou Jiuyuan Gene Engineering、 Suzhou Erye Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Chengdu Baiyu Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Beijing SL Pharmaceutical、 Troikaa Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
注射用エノキサパリンナトリウム市場の定義
市場セグメント
世界の注射用エノキサパリンナトリウム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用エノキサパリンナトリウム市場規模
世界の注射用エノキサパリンナトリウム市場規模:2022年 VS 2029年
世界の注射用エノキサパリンナトリウム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用エノキサパリンナトリウムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用エノキサパリンナトリウム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:40mg、100mg、その他
注射用エノキサパリンナトリウムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:静脈血栓症の予防、深部静脈塞栓症の治療、その他
注射用エノキサパリンナトリウムの用途別グローバル売上・予測

・地域別市場分析
地域別注射用エノキサパリンナトリウム市場規模 2022年と2029年
地域別注射用エノキサパリンナトリウム売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Sanofi、 Teva Pharmaceutical、 Techdow (Hepalink)、 Fresenius Kabi、 Amphastar Pharmaceuticals、 Hangzhou Jiuyuan Gene Engineering、 Suzhou Erye Pharmaceutical、 Nanjing King-friend Biochemical Pharmaceutical、 Chengdu Baiyu Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Beijing SL Pharmaceutical、 Troikaa Pharmaceuticals
...

This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium For Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium For Injection. This report contains market size and forecasts of Enoxaparin Sodium For Injection in global, including the following market information:
Global Enoxaparin Sodium For Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enoxaparin Sodium For Injection Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Enoxaparin Sodium For Injection companies in 2022 (%)
The global Enoxaparin Sodium For Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
40mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Enoxaparin Sodium For Injection include Sanofi, Teva Pharmaceutical, Techdow (Hepalink), Fresenius Kabi, Amphastar Pharmaceuticals, Hangzhou Jiuyuan Gene Engineering, Suzhou Erye Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical and Chengdu Baiyu Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enoxaparin Sodium For Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enoxaparin Sodium For Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, by Type, 2022 (%)
40mg
100mg
Other
Global Enoxaparin Sodium For Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, by Application, 2022 (%)
Prevents Intravenous Thrombosis
Deep Vein Embolism Treatment
Other
Global Enoxaparin Sodium For Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enoxaparin Sodium For Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enoxaparin Sodium For Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enoxaparin Sodium For Injection revenues share in global market, 2022 (%)
Key companies Enoxaparin Sodium For Injection sales in global market, 2018-2023 (Estimated), (Units)
Key companies Enoxaparin Sodium For Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva Pharmaceutical
Techdow (Hepalink)
Fresenius Kabi
Amphastar Pharmaceuticals
Hangzhou Jiuyuan Gene Engineering
Suzhou Erye Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Beijing SL Pharmaceutical
Troikaa Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enoxaparin Sodium For Injection, market overview.
Chapter 2: Global Enoxaparin Sodium For Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Enoxaparin Sodium For Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enoxaparin Sodium For Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enoxaparin Sodium For Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Enoxaparin Sodium For Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enoxaparin Sodium For Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enoxaparin Sodium For Injection Overall Market Size
2.1 Global Enoxaparin Sodium For Injection Market Size: 2022 VS 2029
2.2 Global Enoxaparin Sodium For Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enoxaparin Sodium For Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Enoxaparin Sodium For Injection Players in Global Market
3.2 Top Global Enoxaparin Sodium For Injection Companies Ranked by Revenue
3.3 Global Enoxaparin Sodium For Injection Revenue by Companies
3.4 Global Enoxaparin Sodium For Injection Sales by Companies
3.5 Global Enoxaparin Sodium For Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enoxaparin Sodium For Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enoxaparin Sodium For Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enoxaparin Sodium For Injection Players in Global Market
3.8.1 List of Global Tier 1 Enoxaparin Sodium For Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Enoxaparin Sodium For Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Enoxaparin Sodium For Injection Market Size Markets, 2022 & 2029
4.1.2 40mg
4.1.3 100mg
4.1.4 Other
4.2 By Type – Global Enoxaparin Sodium For Injection Revenue & Forecasts
4.2.1 By Type – Global Enoxaparin Sodium For Injection Revenue, 2018-2023
4.2.2 By Type – Global Enoxaparin Sodium For Injection Revenue, 2024-2029
4.2.3 By Type – Global Enoxaparin Sodium For Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Enoxaparin Sodium For Injection Sales & Forecasts
4.3.1 By Type – Global Enoxaparin Sodium For Injection Sales, 2018-2023
4.3.2 By Type – Global Enoxaparin Sodium For Injection Sales, 2024-2029
4.3.3 By Type – Global Enoxaparin Sodium For Injection Sales Market Share, 2018-2029
4.4 By Type – Global Enoxaparin Sodium For Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Enoxaparin Sodium For Injection Market Size, 2022 & 2029
5.1.2 Prevents Intravenous Thrombosis
5.1.3 Deep Vein Embolism Treatment
5.1.4 Other
5.2 By Application – Global Enoxaparin Sodium For Injection Revenue & Forecasts
5.2.1 By Application – Global Enoxaparin Sodium For Injection Revenue, 2018-2023
5.2.2 By Application – Global Enoxaparin Sodium For Injection Revenue, 2024-2029
5.2.3 By Application – Global Enoxaparin Sodium For Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Enoxaparin Sodium For Injection Sales & Forecasts
5.3.1 By Application – Global Enoxaparin Sodium For Injection Sales, 2018-2023
5.3.2 By Application – Global Enoxaparin Sodium For Injection Sales, 2024-2029
5.3.3 By Application – Global Enoxaparin Sodium For Injection Sales Market Share, 2018-2029
5.4 By Application – Global Enoxaparin Sodium For Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Enoxaparin Sodium For Injection Market Size, 2022 & 2029
6.2 By Region – Global Enoxaparin Sodium For Injection Revenue & Forecasts
6.2.1 By Region – Global Enoxaparin Sodium For Injection Revenue, 2018-2023
6.2.2 By Region – Global Enoxaparin Sodium For Injection Revenue, 2024-2029
6.2.3 By Region – Global Enoxaparin Sodium For Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Enoxaparin Sodium For Injection Sales & Forecasts
6.3.1 By Region – Global Enoxaparin Sodium For Injection Sales, 2018-2023
6.3.2 By Region – Global Enoxaparin Sodium For Injection Sales, 2024-2029
6.3.3 By Region – Global Enoxaparin Sodium For Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Enoxaparin Sodium For Injection Revenue, 2018-2029
6.4.2 By Country – North America Enoxaparin Sodium For Injection Sales, 2018-2029
6.4.3 US Enoxaparin Sodium For Injection Market Size, 2018-2029
6.4.4 Canada Enoxaparin Sodium For Injection Market Size, 2018-2029
6.4.5 Mexico Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Enoxaparin Sodium For Injection Revenue, 2018-2029
6.5.2 By Country – Europe Enoxaparin Sodium For Injection Sales, 2018-2029
6.5.3 Germany Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.4 France Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.5 U.K. Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.6 Italy Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.7 Russia Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.8 Nordic Countries Enoxaparin Sodium For Injection Market Size, 2018-2029
6.5.9 Benelux Enoxaparin Sodium For Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Enoxaparin Sodium For Injection Revenue, 2018-2029
6.6.2 By Region – Asia Enoxaparin Sodium For Injection Sales, 2018-2029
6.6.3 China Enoxaparin Sodium For Injection Market Size, 2018-2029
6.6.4 Japan Enoxaparin Sodium For Injection Market Size, 2018-2029
6.6.5 South Korea Enoxaparin Sodium For Injection Market Size, 2018-2029
6.6.6 Southeast Asia Enoxaparin Sodium For Injection Market Size, 2018-2029
6.6.7 India Enoxaparin Sodium For Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Enoxaparin Sodium For Injection Revenue, 2018-2029
6.7.2 By Country – South America Enoxaparin Sodium For Injection Sales, 2018-2029
6.7.3 Brazil Enoxaparin Sodium For Injection Market Size, 2018-2029
6.7.4 Argentina Enoxaparin Sodium For Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Enoxaparin Sodium For Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Enoxaparin Sodium For Injection Sales, 2018-2029
6.8.3 Turkey Enoxaparin Sodium For Injection Market Size, 2018-2029
6.8.4 Israel Enoxaparin Sodium For Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Enoxaparin Sodium For Injection Market Size, 2018-2029
6.8.6 UAE Enoxaparin Sodium For Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Enoxaparin Sodium For Injection Major Product Offerings
7.1.4 Sanofi Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.2.4 Teva Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.2.5 Teva Pharmaceutical Key News & Latest Developments
7.3 Techdow (Hepalink)
7.3.1 Techdow (Hepalink) Company Summary
7.3.2 Techdow (Hepalink) Business Overview
7.3.3 Techdow (Hepalink) Enoxaparin Sodium For Injection Major Product Offerings
7.3.4 Techdow (Hepalink) Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.3.5 Techdow (Hepalink) Key News & Latest Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Company Summary
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Enoxaparin Sodium For Injection Major Product Offerings
7.4.4 Fresenius Kabi Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.4.5 Fresenius Kabi Key News & Latest Developments
7.5 Amphastar Pharmaceuticals
7.5.1 Amphastar Pharmaceuticals Company Summary
7.5.2 Amphastar Pharmaceuticals Business Overview
7.5.3 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Major Product Offerings
7.5.4 Amphastar Pharmaceuticals Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.5.5 Amphastar Pharmaceuticals Key News & Latest Developments
7.6 Hangzhou Jiuyuan Gene Engineering
7.6.1 Hangzhou Jiuyuan Gene Engineering Company Summary
7.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
7.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Major Product Offerings
7.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.6.5 Hangzhou Jiuyuan Gene Engineering Key News & Latest Developments
7.7 Suzhou Erye Pharmaceutical
7.7.1 Suzhou Erye Pharmaceutical Company Summary
7.7.2 Suzhou Erye Pharmaceutical Business Overview
7.7.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.7.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.7.5 Suzhou Erye Pharmaceutical Key News & Latest Developments
7.8 Nanjing King-friend Biochemical Pharmaceutical
7.8.1 Nanjing King-friend Biochemical Pharmaceutical Company Summary
7.8.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
7.8.3 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.8.4 Nanjing King-friend Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.8.5 Nanjing King-friend Biochemical Pharmaceutical Key News & Latest Developments
7.9 Chengdu Baiyu Pharmaceutical
7.9.1 Chengdu Baiyu Pharmaceutical Company Summary
7.9.2 Chengdu Baiyu Pharmaceutical Business Overview
7.9.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.9.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.9.5 Chengdu Baiyu Pharmaceutical Key News & Latest Developments
7.10 Hebei Changshan Biochemical Pharmaceutical
7.10.1 Hebei Changshan Biochemical Pharmaceutical Company Summary
7.10.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.10.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.10.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.10.5 Hebei Changshan Biochemical Pharmaceutical Key News & Latest Developments
7.11 Beijing SL Pharmaceutical
7.11.1 Beijing SL Pharmaceutical Company Summary
7.11.2 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Business Overview
7.11.3 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Major Product Offerings
7.11.4 Beijing SL Pharmaceutical Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.11.5 Beijing SL Pharmaceutical Key News & Latest Developments
7.12 Troikaa Pharmaceuticals
7.12.1 Troikaa Pharmaceuticals Company Summary
7.12.2 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Business Overview
7.12.3 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Major Product Offerings
7.12.4 Troikaa Pharmaceuticals Enoxaparin Sodium For Injection Sales and Revenue in Global (2018-2023)
7.12.5 Troikaa Pharmaceuticals Key News & Latest Developments
8 Global Enoxaparin Sodium For Injection Production Capacity, Analysis
8.1 Global Enoxaparin Sodium For Injection Production Capacity, 2018-2029
8.2 Enoxaparin Sodium For Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Enoxaparin Sodium For Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enoxaparin Sodium For Injection Supply Chain Analysis
10.1 Enoxaparin Sodium For Injection Industry Value Chain
10.2 Enoxaparin Sodium For Injection Upstream Market
10.3 Enoxaparin Sodium For Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enoxaparin Sodium For Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界の注射用エノキサパリンナトリウム市場予測2023-2029:40mg、100mg、その他] (コード:MMG23JU5540)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の注射用エノキサパリンナトリウム市場予測2023-2029:40mg、100mg、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆